EPGNF.US Epigenomics AG

Healthcare Biotechnology USA Stocks
1.12 USD
Close of Oct 6, 2026
1.12 1.12
Market cap
USD 1.00M
P/E
-
P/B
0.37x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is EPGNF.US undervalued?

Graham number

The Graham number of Epigenomics AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Epigenomics AG fundamental analysis

No fundamental analysis for Epigenomics AG yet.

Epigenomics AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Heidelberg, Germany.

Full company profile